Leader Aspirin 325mg Enteric Coated Tablets deliver regular-strength analgesic and antipyretic efficacy with advanced gastrointestinal protection. The specialized enteric coating delays tablet dissolution until reaching the small intestine, effectively bypassing gastric exposure and significantly reducing the incidence of aspirin-induced gastric irritation and dyspepsia. This delayed-release formulation makes it particularly suitable for individuals requiring chronic aspirin therapy or those with documented aspirin sensitivity. Each tablet provides reliable temporary relief from minor musculoskeletal pain, headache, and fever while maintaining superior tolerability compared to conventional aspirin formulations. The 300-count bottle ensures extended treatment availability for consistent pain management protocols. This evidence-based NSAID represents an optimal choice for patients prioritizing both therapeutic efficacy and gastrointestinal safety during regular analgesic use.